DAFTAR PUSTAKA

American Diabetes Association, 2015, Standars of Medical Care in Diabetes

2015, Diabetes Care,38(suppl. 1).

American Association of Clinical Endocrinologists, 2009, Consensus Type 2

Diabetes Mellitus : An Alogarithm for Glycemic Control, Endocrine
Practice,15(5).

Arauz, P.C., Parrot, M.A., Raskin P., 2002, The Treatment Of Hypertension In
Adult Patients With Diabetes (Technical Review). Diabetes Care,25,134-147.

Anonim, 2005, Pharmaceutical Care untuk Penyakit Diabetes Mellitus, 7-9, 21,
44-50, Depkes RI, Jakarta.

Anonim, 2006a, Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2

di Indonesia, PERKENI, Jakarta.

Anonim, 2006b, Pharmaceutical Care Untuk Penyakit Diabetes Mellitus,

Departemen Kesehatan RI, Jakarta.

Anonim, 2007, Guidelines for Clinical Practice for The Management of Diabetes
Mellitus, Endocr Pract., American Association of Clinical Endocrinologist
Medical, 13 (Suppl 1).

Arguedas, J.A., Leiva, V., Wright, J.M., 2013, Blood Pressure Targets For
Hypertension In People With Diabetes Mellitus. Cochrane Database Syst
Rev;10.

Aslam, M., 2003, Farmasi Klinis Menuju Pengobatan dan Pengharapan Pilihan
Pasien, PT. Gramedia, Jakarta, 293-295.

Bennett, W.L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee,
R., 2011, Comparative Effectiveness and Safety of Medications for Type 2
Diabetes: An Update Including New Drugs and 2-Drug Combinations, Ann
Intern Med., 154, 602-613.

Berry, S.D., Quach, L., Proctec, G.E.,2010, Poor Adherence to Medications May
be Associated With Falls. Journal Gerontol.Ser. A Biol. Sci. Med. Sci,65(5),
553-558.

Borges, A.P., Guidoni, C.M., Ferreira, L.D., Freitas, O., Pereira, L.R.L., 2010,
The Pharmaceutical Care of Patients with Type 2 Diabetes Mellitus,
Pharmacy World & Science32, 730-736.

60
 61

Center for Disease Control and Prevention. National Diabetes Fact Sheet; General
Information and National Estimates on Diabetes in The United States, 2003,
revised ed. Atlanta: U.S. Department of Health and Human Service,Centers
for Disease Control and Prevention, 2004.

Cipolle, R.J., Linda, M.S., Morley, P.C., 1998, Pharmaceutical Care Practice,
The McGraw-Hill Companies.Inc., 75-83, New York.

Corwin, J.E., 2001, Patofisiologi, , 618-645, EGC, Jakarta.

Craig, M. E., Hattersley, A., Donaghue, K, C., 2009, Definition, Epidemiology

and Classification od Diabetes in Children and Adolescent, Pediatr Diabetes.,
10(12), 3-12.

Dinas Kesehatan Daerah Istimewa Yogyakarta (Dinkes DIY), 2012, Profil

Kesehatan Provinsi Daerah Istimewa Yogyakarta 2011, Dinas Kesehatan
DIY, Yogyakarta.

Fioretto, P., Steffes, M.W., Sutherland, D.E.R., 1998, Reversal Of Lesions Of

Diabetic Nephropathy After Pancreas Transplantation. N Engl J Med.339, 69-
75.

Gerich, J.E.,1989, Oral Hypoglicemic Agents.N Engl J Med321, 1232-1245.

Hibbard, J.H., and Pope, C.R., 1983,Gender Roles Illness Orientation And Use Of
Medical Services.Soc Sci Med,17, 129-137.

Huri, H. Z. and Hoo Fun Wee, 2013, Drug Related Problems In Type 2 Diabetes
Patients With Hypertension: A Cross-Sectional Retrospective Study, BMC
Endocrine Disorders 2013, 13, 2.

Jackson, G., Morrison, G., Morrison, C. L., Weston, P. J., 2010, Insulin Treated
Diabetes And Driving: What Is The Patients Knowledge Of Current
Regulations, British Journal of Diabetes & Vascular Disease10,31.

Johnson, J.A., Majudar, S,R., Simpson, S.H., Toth, E.I., 2006, Decreased
Mortality Associated With the Use of Metformin Compared With
Sulfonylurea Monoteraphy in Type 2 Diabetes, Diabetes Care, 25(12), 2244-
2248.

Kroon, L.A. and Wiliams, C., 2012, Diabetes Melitus, in: Alldredge, B.K.,
Corelli, R.L., Ernst, M.E. (Eds.), Koda-Kimble and Youngs Applied
Therapeutics : The Clinical Use of Drugs, 12th edition, Lippincott Williams &
Wilkins, US.
 62

Liebman, J., 2008, Quality Improvement in Diabetes Care Using Community

Health Worker, Clinical Diabetes, 26(2), 75-76.

Morisky, D.E., Ang, A., Krousel, W.M., Ward, H. J., 2008, Predictive Validity of
A Medication Adherence Measure in an Outpatient Setting, J. Clin. Hypertens,
10(5), 348-354.

Morris, A., Smith, E., Dowall, J., 2003, The Problem of Polypharmacy in Type 2
Diabetes, Br J Diabetes Vasc Dis, 3, 54-56.

Nathan, M.D., Buse, J.B., Davidson, M.B., 2009, Diabetes: Medical Management
of Hyperglycemia in Type 2 A Consensus Algorithm for the Initiation and
Adjustment of Therapy A Consensus Statement of the American Diabetes
Association and the European Association for the Study of Diabetes,Clinical
Diabetes, 27(1), 4-14.

Paula, A., Molino, G., Ferreira, D., Osvaldo, L.P., 2009, The Pharmaceutical Care
Of Patients With Type 2 Diabetes Mellitus. Pharm World Sci, 3, 9428.

Paulino, E.I., Bouvy, M.L., Gastelurrutia, M.A., Guerreiro, M., Buurma, H., 2004,
Drug Related Problems Identified By European Community Pharmacist In
Discharged From Hospital, Pharm World Sci, 26, 353-360.

Perkumpulan Endorinologi Indonesia (PERKENI), 2011, Konsensus

Pengendalian dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2011,
PERKENI, Jakarta.

Prest, M., 2003, Penggunaan Obat Pada Lanjut Usia dalam Aslam, M., Tan, C. K.,
dan Prayitno, A., Farmasi Klinis: Menuju Pengobatan Rasional dan
Penghargaan Pilihan Pasien, 203-204, Gramedia, Jakarta.

Price, S.A., and Lorraine M. Wilson, 1995, Patofisiologi: Konsep Klinis Proses-
Proses Penyakit Edisi 4, EGC, Jakarta.

Ragucci, K.R., 2005, Effectiveness of Pharmacist-Administered Diabetes Mellitus

Education and Management Services, Pharmacotherapy.,25(12), 1809-1816.

Rodbard, H.W., Blonde, L., Braithwaite, S.S., Brett, E.E., Cobin, R.H.,
Handelsman, Y., 2007, American Association of Clinical Endocrinologist
Medical Guidelines for Clinical Practice for the Management of Diabetes
Mellitus, Endocr Pract., 13(1),3-68.

Roger P.,2006, Polypharmacy as A Risk Factor In The Treatment Of Type 2

Diabetes, Diabetes Spectrum, 19(1), 13-16.
 63

Rovers, J.P., Currie, J.D., 2003, A Practical Guide to Pharmaceutical Care,

second edition, American Pharmaceutical Association, Washington D.C, 15-
24, 54-61.

Sabatae, E., 2003, Adherence to Long-Term Therapies: Evidence for Action.

World Health Organization.

Sacks, D.B., Arnold, M., Bakris, G.L., Bruns, D.E., Horvath, A.R., Kirkman,
M.S., 2011, Guidelines and Recommmendation for Laboratory Analysis in the
Diagnosis and Management of Diabetes Mellitus, Diab Care., 34,e61-e99.

Sharpe, P.A., Clark, N.M., Janz, N.K., 1991, Differences In The Impact And
Management Of Heart Disease Between Older Women And Men.Women &
Health,17, 25-43.

Saseen, J.J., and Machlaughlin, E.J., 2011. Hypertension.in: Dipiro, J.T., Talbert,
R.L., Yee, Gary., Matzke, G.R., Wells, B.G., et al., Pharmacotherapy: A
Pathophysiology Approach, 8thedition. The McGraw-Hill Companies, Inc.,
New York.

Setter, S.M., White, J.R., Campbell, R.K., 2015, Diabetes. In: Kasper et al,
Harissons Principles of Internal Medicine, 19thEdition. McGraw-Hill
Education. New York.

Tandra, H., 2008, Segala Sesuatu yang Harus Anda Ketahui Tentang Diabetes,
72-183, PT Gramedia Pustaka Utama, Jakarta.

Tjay, T.H.and Rahardja, K., 2002, Obat-Obat Penting, Edisi Kelima, Gramedia,
Jakarta, 536-547, 693-709.

Triplitt, C.L., Charles, A., Isley, W.L., 2008, Diabetes Mellitus, dalam Dipiro,
J.T., dkk., Pharmacotherapy: A Pathophysiology Approach, 7th edition, 1205-
1241, The McGraw-Hill Companies, Inc., USA.

Vinks, T.H., de Koning F.H., de Lange T.M., Egberts T.C.,2006, Identification of

Potential Drug-Related Problems in The Elderly: The Role of The Community
Pharmacist. Pharm World Sci, 28, 30-33.

Weiss, A., and Michael, M.F.M., 2009, In the Beginning: Setting the Stage for
Effective Diabetes Care. Clinical Diabetes, 27(2), 150-151.

Wells, G.B., and Dipiro, J., 2009, Pharmacotherapy Handbook, 7th Edition, 210-
226The McGraw-Hill Companies, Inc., New York.
 64

Wild, S., Roglic, G., Green,A., Sicree, R., King, H., 2004, Global Prevalence of
Diabetes: Estimates for the Year 2000 and Projections for 2030, Diabetes
Care, 27,1047-1053.